US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals: market research reports

The pharmaceutical industry is a $1 trillion-dollar sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.

  • Biopharmaceuticals (255)
  • Diseases & Conditions (3944)
  • Drug Delivery (279)
  • Therapeutic Area (7129)
  • Vaccines (719)
RSS Feeds

Pharmaceuticals market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024
9/6/2014 | published by: Visiongain
... of kinase inhibitors? Now get the latest analysis for those cancer treatments. There you explore developments, other trends, results, opportunities and revenue forecasts. Visiongain’s new report shows you what’s possible for drugs using protein kinase ...  |  read more...
USD 2,986
PHARMACEUTICAL MARKET INDIA 2014-2020 : Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines
8/1/2014 | published by: Kelly Scientific Publications
... Biosimilars, Generics & Vaccines” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. This report scrutinises top Indian pharmacos and their battle ...  |  read more...
USD 2,000
Latest Guidebook for Conducting Pharma Clinical Trials - China: From Regulations to Practice (2014 Edition)
7/25/2014 | published by: Access China Management Consulting Ltd.
... of the largest healthcare markets around the world. Along with sustained economic and population growth as well as an ageing population, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. ...  |  read more...
USD 1,495
Pharmaceuticals and Healthcare Report Q3 2014 - Ghana
7/16/2014 | published by: Business Monitor International
... remain positive for the sectorwith the government's focus on domestic pharmaceutical sector, greater foreign pharmaceutical companyinterest in the country and capacity building initiatives for bringing global quality control standards toGhanaian pharmaceutical industry will spur domestic ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Moldova
7/16/2014 | published by: Business Monitor International
... with the EU inJune 2014, which would strengthen the business environment and improve the regulatory structure andaccess to the pharmaceutical market in the country. Moldova is undertaking a reform of its healthcaresector with the World ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Spain
7/16/2014 | published by: Business Monitor International
... to drugmakers operating in the country. Despite calls made by companies for theimplementation of a system that adequately rewards innovation and supports investment in futuremedicines, the government is likely to remain committed to fiscal consolidation ...  |  read more...
USD 1,295
Advancement in Liquid Dosage Excipients (Parenteral & Transdermal)
7/16/2014 | published by: Frost & Sullivan
... the year 2018 with a CAGR of ??%. The total global parenteral finished products market is estimated to be worth $??billion. Parenteral finished products include vials with sterile liquids or powders to be reconstituted for ...  |  read more...
USD 3,000
Pharmaceuticals and Healthcare Report Q3 2014 - Slovakia
7/16/2014 | published by: Business Monitor International
... agencyTASR. The government added that after adding contributions from the state budget, the total funds that havebeen allocated for developing healthcare infrastructure will be EUR300mn (USD417.3mn). The governmentplans to allocate these funds to projects in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Greece
7/16/2014 | published by: Business Monitor International
... will continue to target the pharmaceutical and healthcare industry to reduce public spending.We highlight, however, that the generic drug sector and private healthcare industry will present somegrowth opportunities in the country. Headline Expenditure Projections Pharmaceuticals: ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Lithuania
7/16/2014 | published by: Business Monitor International
... The upcoming switch to theeuro promises to boost purchasing power and stabilise the pharmaceutical market, albeit at the cost ofincreasing healthcare expenditure. Ceding control of monetary policy to Brussels leaves Lithuania withlittle leeway to increase ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Serbia
7/16/2014 | published by: Business Monitor International
... reduce itsdebt burden. However, pharmaceutical spending is also a target for cuts. Local drug makers are set to feelthe worst of these new measures as they cannot compete on cost compared to larger players in ...  |  read more...
USD 1,295
Radiation Therapy in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... 725 developmental projects in cancer. In addition, there are 7 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 140 drugs. Radiation Therapy In Oncology Drug Pipeline Update ...  |  read more...
USD 6,746
Leukemia Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... projects in cancer. In addition, there are 5 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 127 drugs. Leukemia Drug Pipeline Update lists all drugs and gives ...  |  read more...
USD 6,746
Brain Cancer Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of brain cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 188 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Colorectal Cancer Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of colorectal cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 253 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
NOD-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... more than 20 members in mammals and plays a pivotal role in the recognition of intracellular ligands. There are today 87 companies plus partners developing 75 NOD-like receptor signaling pathway targeting drugs in 239 developmental ...  |  read more...
USD 4,496
Hematological Cancers Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of hematological cancers. The rational for this plethora of treatment strategies is based on our increasing understanding of the 356 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Jak-STAT Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... for development and homeostasis in animals, from humans to flies. In mammals, the JAK/STAT pathway is the principal signaling mechanism for a wide array of cytokines and growth factors. There are today 252 companies plus ...  |  read more...
USD 6,746
IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... drugs in 1307 developmental projects in cancer. In addition, there are 5 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 152 drugs. Il-2 Signaling Pathway In Oncology ...  |  read more...
USD 6,746
Immunotherapy in Oncology: Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 135 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 374 drug targets that are included ...  |  read more...
USD 11,025
Leukemia Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... signaling pathways for the treatment of leukemia. The rational for this plethora of treatment strategies is based on our increasing understanding of the 250 drug targets that are included in this drug-pathway analyzing tool. No ...  |  read more...
USD 6,746
Lymphoma Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... signaling pathways for the treatment of lymphoma. The rational for this plethora of treatment strategies is based on our increasing understanding of the 226 drug targets that are included in this drug-pathway analyzing tool. No ...  |  read more...
USD 6,746
Aestus Therapeutics, Inc. - Product Pipeline Review - 2014
7/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Aestus Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Oncology Drug Pathway Analyzer (Premium Version)
7/15/2014 | published by: BioSeeker Group AB
... their pathways are the critical link between drugs and their role in the treatment of cancer. This highly unique interactive tool is based on BioSeeker’s linking of hundreds of drug targets in many different types ...  |  read more...
USD 44,550
Oncology Drug Pathway Analyzer (Standard Version)
7/15/2014 | published by: BioSeeker Group AB
... their pathways are the critical link between drugs and their role in the treatment of cancer. This highly unique interactive tool is based on BioSeeker’s linking of hundreds of drug targets in many different types ...  |  read more...
USD 31,050
< prev 1    3  4  5  6  7  8  9  10  
 
Our Clients